CORC

在结果中检索

CORC

浏览/检索结果: 共9条，第1-9条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Induced CD20 Expression on B-Cell Malignant Cells Heightened the Cytotoxic Activity of Chimeric Antigen Receptor Engineered T Cells 期刊论文
2019, 卷号: 30, 期号: 4,SI, 页码: 497-510
作者:  Xu, Yingxi;  Li, Saisai;  Wang, Ying;  Liu, Jia;  Mao, Xinhe
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction 期刊论文
2018, 卷号: 14, 期号: 13, 页码: 1845-1858
作者:  He, Bin;  Dai, Longfei;  Zhang, Xiaoqian;  Chen, Diyu;  Wu, Jingbang
收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03
A new HDAC inhibitor cinnamoylphenazine shows antitumor activity in association with intensive macropinocytosis 期刊论文
2017, 卷号: 8, 期号: 9, 页码: 14748-14758
作者:  Zhu, Bing-yan;  Shang, Bo-yang;  Du, Yue;  Li, Yi;  Li, Liang
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer 期刊论文
2016, 卷号: 28, 期号: 4, 页码: 444-451
作者:  Hu, Xingsheng;  Wang, Lin;  Lin, Lin;  Han, Xiaohong;  Dou, Guifang
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
A phase I trial of an oral subtype-selective histone deacetylase inhibitor,chidamide,in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer 期刊论文
2016, 卷号: 28, 期号: 4, 页码: 444-451
作者:  Hu Xingsheng;  Wang Lin;  Lin Lin;  Han Xiaohong;  Dou Guifang
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma 期刊论文
2015, 卷号: 26, 期号: 8, 页码: 1766-1771
作者:  Shi, Y.;  Dong, M.;  Hong, X.;  Zhang, W.;  Feng, J.
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13
Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy 期刊论文
2013, 卷号: 20, 期号: 14, 页码: 1858-1886
作者:  Li, Jiyang;  Li, Guangqiang;  Xu, Wenqing
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity 期刊论文
2012, 卷号: 69, 期号: 4, 页码: 901-909
作者:  Ning, Zhi-Qiang;  Li, Zhi-Bin;  Newman, Michael J.;  Shan, Song;  Wang, Xin-Hao
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13
Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas 期刊论文
2012, 卷号: 69, 期号: 6, 页码: 1413-1422
作者:  Dong, Mei;  Ning, Zhi-Qiang;  Xing, Pu-Yuan;  Xu, Jia-Lian;  Cao, Hai-Xiang
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace